These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 29221169)
21. Preclinical study of cinobufagin as a promising anti-colorectal cancer agent. Lu XS; Qiao YB; Li Y; Yang B; Chen MB; Xing CG Oncotarget; 2017 Jan; 8(1):988-998. PubMed ID: 27894091 [TBL] [Abstract][Full Text] [Related]
22. Activating AMP-activated protein kinase by an α1 selective activator compound 13 attenuates dexamethasone-induced osteoblast cell death. Guo S; Mao L; Ji F; Wang S; Xie Y; Fei H; Wang XD Biochem Biophys Res Commun; 2016 Mar; 471(4):545-52. PubMed ID: 26891866 [TBL] [Abstract][Full Text] [Related]
23. Protein phosphatase 2A and DNA-dependent protein kinase are involved in mediating rapamycin-induced Akt phosphorylation. Li Y; Wang X; Yue P; Tao H; Ramalingam SS; Owonikoko TK; Deng X; Wang Y; Fu H; Khuri FR; Sun SY J Biol Chem; 2013 May; 288(19):13215-24. PubMed ID: 23536185 [TBL] [Abstract][Full Text] [Related]
24. Chiou JT; Shi YJ; Wang LJ; Huang CH; Lee YC; Chang LS Toxins (Basel); 2019 Sep; 11(9):. PubMed ID: 31547294 [TBL] [Abstract][Full Text] [Related]
25. LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation. Ho WS; Sizdahkhani S; Hao S; Song H; Seldomridge A; Tandle A; Maric D; Kramp T; Lu R; Heiss JD; Camphausen K; Gilbert MR; Zhuang Z; Park DM Cancer Lett; 2018 Feb; 415():217-226. PubMed ID: 29199006 [TBL] [Abstract][Full Text] [Related]
26. Dual PI3K-BRD4 Inhibitor SF1126 Inhibits Colorectal Cancer Cell Growth in Vitro and in Vivo. Qin AC; Li Y; Zhou LN; Xing CG; Lu XS Cell Physiol Biochem; 2019; 52(4):758-768. PubMed ID: 30933440 [TBL] [Abstract][Full Text] [Related]
27. Pre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells. Zhijun H; Shusheng W; Han M; Jianping L; Li-Sen Q; Dechun L Tumour Biol; 2016 Aug; 37(8):10257-67. PubMed ID: 26831668 [TBL] [Abstract][Full Text] [Related]
28. Lnc-THOR silencing inhibits human glioma cell survival by activating MAGEA6-AMPK signaling. Xue J; Zhong S; Sun BM; Sun QF; Hu LY; Pan SJ Cell Death Dis; 2019 Nov; 10(11):866. PubMed ID: 31727877 [TBL] [Abstract][Full Text] [Related]
29. Anthocyanins are novel AMPKα1 stimulators that suppress tumor growth by inhibiting mTOR phosphorylation. Lee YK; Lee WS; Kim GS; Park OJ Oncol Rep; 2010 Dec; 24(6):1471-7. PubMed ID: 21042741 [TBL] [Abstract][Full Text] [Related]
30. AMPK activation by GSK621 inhibits human melanoma cells in vitro and in vivo. Chen L; Chen Q; Deng G; Kuang S; Lian J; Wang M; Zhu H Biochem Biophys Res Commun; 2016 Nov; 480(4):515-521. PubMed ID: 27751856 [TBL] [Abstract][Full Text] [Related]
31. Exopolysaccharides isolated from Rhizopus nigricans induced colon cancer cell apoptosis in vitro and in vivo via activating the AMPK pathway. Lu Y; Zhang X; Wang J; Chen K Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894839 [TBL] [Abstract][Full Text] [Related]
32. Activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells. Chen MB; Zhang Y; Wei MX; Shen W; Wu XY; Yao C; Lu PH Cell Signal; 2013 Oct; 25(10):1993-2002. PubMed ID: 23712032 [TBL] [Abstract][Full Text] [Related]
33. Targeting colorectal cancer cells by a novel sphingosine kinase 1 inhibitor PF-543. Ju T; Gao D; Fang ZY Biochem Biophys Res Commun; 2016 Feb; 470(3):728-734. PubMed ID: 26775841 [TBL] [Abstract][Full Text] [Related]
34. The B56γ3-containing protein phosphatase 2A attenuates p70S6K-mediated negative feedback loop to enhance AKT-facilitated epithelial-mesenchymal transition in colorectal cancer. Hsiao KC; Ruan SY; Chen SM; Lai TY; Chan RH; Zhang YM; Chu CA; Cheng HC; Tsai HW; Tu YF; Law BK; Chang TT; Chow NH; Chiang CW Cell Commun Signal; 2023 Jul; 21(1):172. PubMed ID: 37430297 [TBL] [Abstract][Full Text] [Related]
35. miR-107 inhibition upregulates CAB39 and activates AMPK-Nrf2 signaling to protect osteoblasts from dexamethasone-induced oxidative injury and cytotoxicity. Zhuang Y; Wang S; Fei H; Ji F; Sun P Aging (Albany NY); 2020 Jun; 12(12):11754-11767. PubMed ID: 32527986 [TBL] [Abstract][Full Text] [Related]
36. Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation. Yu HC; Lin CS; Tai WT; Liu CY; Shiau CW; Chen KF J Biol Chem; 2013 Jun; 288(25):18249-59. PubMed ID: 23677989 [TBL] [Abstract][Full Text] [Related]
37. CDC25B partners with PP2A to induce AMPK activation and tumor suppression in triple negative breast cancer. Cairns J; Ly RC; Niu N; Kalari KR; Carlson EE; Wang L NAR Cancer; 2020 Dec; 2(4):zcaa039. PubMed ID: 33385163 [TBL] [Abstract][Full Text] [Related]
38. Caffeic acid derivatives inhibit the growth of colon cancer: involvement of the PI3-K/Akt and AMPK signaling pathways. Chiang EP; Tsai SY; Kuo YH; Pai MH; Chiu HL; Rodriguez RL; Tang FY PLoS One; 2014; 9(6):e99631. PubMed ID: 24960186 [TBL] [Abstract][Full Text] [Related]
39. Hyperphosphorylation of PP2A in colorectal cancer and the potential therapeutic value showed by its forskolin-induced dephosphorylation and activation. Cristóbal I; Rincón R; Manso R; Madoz-Gúrpide J; Caramés C; del Puerto-Nevado L; Rojo F; García-Foncillas J Biochim Biophys Acta; 2014 Sep; 1842(9):1823-9. PubMed ID: 24997451 [TBL] [Abstract][Full Text] [Related]
40. Activation of AMP-activated protein kinase by compound 991 protects osteoblasts from dexamethasone. Xu YY; Chen FL; Ji F; Fei HD; Xie Y; Wang SG Biochem Biophys Res Commun; 2018 Jan; 495(1):1014-1021. PubMed ID: 29175330 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]